MICHAEL A. HAJOST - 07 Feb 2025 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)

Role: Chief Financial Officer
Signature: /s/ Stephen A. Martin, attorney-in-fact
Issuer symbol: DNMRQ
Transactions as of: 07 Feb 2025
Net transactions value: -$355
Form type: 4
Filing time: 10 Feb 2025, 16:30:05 UTC
Previous filing: 05 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNMR	Class A Common Stock	Options Exercise		+859	+48%		2,635	07 Feb 2025	Direct	F1
transaction	DNMR	Class A Common Stock	Tax liability	$355	-301	-11%	$1.18	2,334	07 Feb 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNMR	Restricted Stock Units	Options Exercise	$0	-859	-100%	$0.000000	0	07 Feb 2025	Common Stock	859		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Danimer Scientific Class A common stock.
F2	On November 12, 2024, the common stock of Danimer Scientific, Inc. reverse split 1 for 40.
F3	On March 31, 2022, the reporting person was granted 103,092 restricted stock units on a pre-reverse split basis. These awards vested in thirds respectively on February 7, 2023, February 7, 2024 and February 7, 2025.